Volume 16, Number 1—January 2010
Research
Methicillin-Resistant and -Susceptible Staphylococcus aureus Infections in Dogs
Table 4
Clinical outcome characteristics for dogs with MRSA and MSSA infections, United States and Canada, 2001–2007*
| Variable | MRSA, no. (%) dogs, n = 40 | MSSA, no. (%) dogs, n = 80† | Odds ratio (95% CI) | p value |
|---|---|---|---|---|
| Surgery required because of infection | ||||
| No | 24 (60) | 46 (57.5) | Ref | |
| Yes |
16 (40) |
34 (42.5) |
0.89 (0.37–2.12) |
0.84 |
| Outcome | ||||
| Discharged | 36/39 (92.3) | 69/77 (89.6) | Ref | |
| Euthanized | 3/39 (7.7) | 8/77 (10.4) | 0.63 (0.06–4.10) | 0.71 |
*MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; CI, confidence interval; Ref, referent category. Dogs with MRSA (case-patients) and MSSA (controls) infections were matched for veterinary referral hospital and date of admission.


